Boutique Venture Partners

Specializing in early stage investments in healthcare and life sciences

Subscribe
Get in touch

About us

We are a team of hardcore scientists and clinicians who partner with authentic founders to create innovative and disruptive approaches that improve health and wellness.

Our philosophy

Our Team

Dr. Rami El Assal

Managing Partner & Co-founder

Dr. S. Thad Connelly

Managing Partner & Co-founder

Dr. Ryan Spitler

Partner & Member of Investment Committee

Dr. Justin Young

Venture Partner

Yaser Alorainy

Venture Partner

Dr. Jay Gupta

Venture Partner

Matthew Wahlrab

Venture Partner

Kadambari (Kad) Beelwar

Venture Fellow

Julien Hédou

Entrepreneur in Residence

Our Advisors

Prof. George Church

Scientific Advisor
Harvard University
Member of National Academy of Science

Prof. Zhenan Bao

Scientific Advisor
Stanford University
Member of National Academy of Engineering

Prof. Ophir Klein

Medical Advisor
UCSF
Member of National Academy of Medicine

Martin Schmieg

Investment Advisor
CFO of Adv. Bionics & Sirna
(Two > 1 billion Exits)

Dr. Bassam El Fahmawi

Scientific & Entrepreneurial Advisor
Founder of Mawi DNA Technologies

Dr. Craig Rochester

Patent Attorney & Fund Advisor
JD/PhD (Genetics)
Intellectual Ventures (former)
Meet all the team

Approach

Boutique Venture Partners focuses on emerging healthcare and life science solutions to make a significant impact at scale. We leverage our deep connections within the healthcare ecosystem to get early access to innovations and discoveries coming out of premiere academic institutes and industry. We pay particular attention to early-stage companies that are:

01

Transforming

Developing novel approaches/platforms with solid IP

02

Authentic

Founded by authentic entrepreneurs with deep domain expertise

03

Impactful

Have large growth potential while demonstrating societal impact

Portfolio

PrinterPrezz

Where Ideas Become Reality- Life changing medical devices for everyone

Seed & Series A Lead

Filtricine

Transforming cancer management

Series Seed Lead

Docbot

Transforming GI disease diagnosis and healthcare decision making

Seed & Series A

miRecule

Early-stage biotechnology company developing RNA-based therapeutics

Seed

Mesentech

Developed novel chemistry that selectively delivers pharmaceuticals to a specific tissue

Seed
Browse all Investments

News

Follow us on Linkedin

We are Proud to be Recognized among the Top 25 Healthcare Investors in 2022

We are Delighted that our Portfolio Company, miRecule, Entered into a Strategic Collaboration with Sanofi with Potential Future Milestone Payments of nearly $400 Million

We are Happy to Lead PrinterPrezz's Series A Financing

PrinterPrezz Inc combines additive manufacturing and nanotechnology with a foundry ecosystem to develop medical devices from concept and design through FDA approval and volume production.

We are Happy to Lead Filtricine's Seed Funding Round

Filtricine, Inc. is developing a proprietary targeted medical food technology to help cancer patients manage their diseases.

Our Founding Partners', Dr. Rami El Assal & Dr. S. Thad Connelly, Book Series is Published!

We are happy to receive the print of two-volume book series on Early Detection and Treatment of Head and Neck Cancers.

Read all news